Treace Medical Concepts, Inc.
Sean Scanlan, PhD has extensive work experience in the medical and scientific field. Sean is currently serving as the Chief Innovation Officer at Treace Medical Concepts, Inc. Sean'sprevious roles at the company include Senior Vice President and Vice President of Marketing & Medical Education, as well as Director of Marketing and Product Growth Manager.
Prior to joining Treace Medical Concepts, Inc., Sean worked as a Consultant at Cummings Scientific, LLC. Sean also served as an R&D Engineer at Smith & Nephew Endoscopy, where they led various projects and contributed to the development of a CT-based surgical planning software.
Sean's academic background includes positions as a Postdoctoral Scholar at Stanford University and a Graduate Research Assistant. During their time at Stanford, they conducted collaborative research in the fields of Orthopaedic Surgery, Engineering, and Radiology, focusing on surgical technique evaluation and cartilage morphology.
Additionally, Sean has worked as an R&D and Marketing Consultant at Moximed, and as an R&D Intern at RTI Biologics.
Sean Scanlan earned a Bachelor of Science degree in Engineering Science from the University of Florida, where they attended from 2000 to 2004. Sean then pursued further education at Stanford University, completing a Master of Science degree in Mechanical (Biomechanical) Engineering from 2004 to 2006. Scanlan continued their studies at Stanford and obtained a PhD in Mechanical (Biomechanical) Engineering, which they completed between 2006 and 2010.
Treace Medical Concepts, Inc.
1 followers
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients. For more information, please visit www.treace.com. The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. For complete risk and benefit information, visit Treace.com. **Please note** Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants. 1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21. 2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71. 3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.